Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Aditxt
AddedFeb 19, 2024
UpdatedJul 4, 2026
Aditxt

Aditxt

Public

Aditxt™: A biotech innovator enhancing life quality through nucleic acid-based immune health solutions.

HQ
Richmond, VA, US
Founded
2017
Overview
Compare
Fundraising
Employees
Website

Aditxt™ is a biotech innovation company founded with the mission to prolong life and enhance its quality by improving immune system health. The company focuses on nucleic acid-based technology to develop solutions that restore immune tolerance and provide long-lasting treatment for chronic diseases. Their flagship initiative, Adimune™, is in the pre-clinical stage and aims to address severe conditions by developing a robust pipeline of medications. Aditxt™ targets a global market, aiming to deliver significant advancements in immune health.

Notable affiliated individuals include Ruben Mislang, who plays a key role in the company's strategic direction. Aditxt™ has garnered attention from various investors interested in biotech innovations. Key achievements include the development of Adimune™, which holds promise for transforming the treatment landscape for chronic diseases. The overall impact of Aditxt™ lies in its potential to significantly improve the quality of life for individuals with severe immune-related conditions through pioneering nucleic acid-based therapies.

Aditxt - Similar Companies

Inimmune logo

Inimmune

inimmune.com

Adimab logo

Adimab

adimab.com

Adarx Pharmaceuticals logo

Adarx Pharmaceuticals

adarx.com

Adaptive Biotechnologies logo

Adaptive Biotechnologies

ImmuneID logo

ImmuneID

Aibios logo

Aibios

aibios.com

Adcentrx Therapeutics logo

Adcentrx Therapeutics

adcentrx.com

Nantkwest logo

Nantkwest

Adtech Pharma logo

Adtech Pharma

adtechpharma.com

AIM Immunotech logo

AIM Immunotech

aimimmuno.com

Theradaptive logo

Theradaptive

theradaptive.com

Imidomics logo

Imidomics

imidomics.com

Intellimedix logo

Intellimedix

Aviceda Therapeutics logo

Aviceda Therapeutics

avicedarx.com

Adrx logo

Adrx

adrxpharma.com

Aditxt - Quick Facts

Who are Aditxt's competitors?

Companies similar to Aditxt include Inimmune, Adimab, Adarx Pharmaceuticals and Adaptive Biotechnologies.

When was Aditxt founded?

Aditxt was founded in 2017.

Where is Aditxt's headquarters located?

Aditxt's headquarters is located in Richmond, VA, US.

When was Aditxt's last funding round?

Aditxt's most recent funding round was for $6M (USD) in December 2023.

How much has Aditxt raised to-date?

As of Dec 29, 2023, Aditxt has raised a total of $60.3M (USD).

How many employees does Aditxt have?

Aditxt has 175 employees as of Feb 6, 2024.

Aditxt - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Immune Health
  • Therapeutics
Tags
  • Healthtech
Unique IDs
  • secCik: 0001726711
  • ticker: ADTX
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 14 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research